Inventor · disambiguated record
Eugen Leo
Also filed as: LEO EUGEN
6 granted patents·5 pending applications·74 citations·filing 2006–2025
78Inventor score
Top patents by PatentIndex Score
11 records- 0196US8007796B2Means and methods for the treatment of tumorous diseasesMICROMET AG·Filed 2006·Granted Aug 30, 2011·69 cites·18 claims
- 0280US11154617B2Means and methods for the treament of B cell non-hodgkin lymphoma and B cell leukemiaBAEUERLE PATRICK·Filed 2011·Granted Oct 26, 2021·4 cites·10 claims
- 0369US12497447B2Anti-GDF15 antibody and a dosage regimen for the treatment of cancerCATALYM GMBH·Filed 2025·Granted Dec 16, 2025·0 cites·17 claims
- 0469US9688988B2Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic diseaseISARNA THERAPEUTICS GMBH·Filed 2014·Granted Jun 27, 2017·1 cites·11 claims
- 0569US2022088196A1Means and Methods for Treating Tumorous DiseasesAMGEN RES MUNICH GMBH·Filed 2021·Application pending·0 cites
- 0663US2024043517A1Anti-gdf15 antibody and a dosage regimen for the treatment of cancerCATALYM GMBH·Filed 2023·Application pending·0 cites
- 0756US2023310607A1Methods of selecting a patient for treatment of a mage-a1 positive solid tumor, of predicting whether a patient being diagnosed with mage-a1 positive solid tumor will be responsive to treatment of this tumor and of treating a patient being diagnosed with such a mage-a1 positive solid tumor as well as corresponding pharmaceutical compositions and diagnostic kitsT KNIFE GMBH·Filed 2022·Application pending·0 cites
- 0854US2019144865A1Modified tgf-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic diseaseISARNA THERAPEUTICS GMBH·Filed 2018·Application pending·0 cites
- 0952US10125368B2Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic diseaseISARNA THERAPEUTICS GMBH·Filed 2017·Granted Nov 13, 2018·0 cites·9 claims
- 1051US2025304673A1Anti-gdf15 antibody used in a combination treatment of specific patient groups and a dosage regimen for the treatment of cancerCATALYM GMBH·Filed 2025·Application pending·0 cites
- 1137US11207341B2TGF-beta oligonucleotide for use in treatment of ophthalmic diseasesISARNA THERAPEUTICS GMBH·Filed 2017·Granted Dec 28, 2021·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Eugen Leo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →